Aurelio Maggio: How Is The Treatment Landscape Of Thrombotic Thrombocytopenic Purpura Evolving?
Aurelio Maggio, President of Franco and Piera Cutino Foundation, shared a post on LinkedIn:
“How is the treatment landscape of thrombotic thrombocytopenic purpura (TTP) evolving?
In this new GARDEN Experts Insights article, Prof. Raimondo De Cristofaro discusses current therapeutic strategies, remaining clinical challenges, and future perspectives in the management of TTP.
A valuable expert contribution on one of the most severe rare hematological disorders.”
Global Hematological Rare Diseases Alliance (GARDEN) shared a post on LinkedIn:
“What are the key challenges and opportunities in the treatment of thrombotic thrombocytopenic purpura (TTP)?
In this new contribution from the GARDEN Experts Insights series, Prof. Raimondo De Cristofaro shares his perspective on the evolving landscape of TTP management, discussing current therapeutic approaches, unresolved clinical challenges, and emerging strategies that may further improve patient outcomes.
A valuable expert insight into one of the most complex and potentially life-threatening rare hematological disorders.”
Stay updated with Hemostasis Today.
-
Jun 15, 2026, 13:13Christina Ornauer: Exploring the Latest Advances in Hematology at EHA 2026
-
Jun 15, 2026, 13:05Angelo Zanniti: Back from EHA 2026 Congress
-
Jun 15, 2026, 12:56Chiara Pirillo: Building Global Connections at EHA 2026
-
Jun 15, 2026, 12:50Marina Planas: MRD and Molecular Monitoring Take Center Stage at EHA 2026
-
Jun 15, 2026, 12:46Moonmoon Kazi: Climb Bio Presents Phase 1b ITP Trial Data at EHA 2026
-
Jun 15, 2026, 12:44Wolfgang Miesbach: Base Editing and the Future of Sickle Cell Disease Therapy
-
Jun 15, 2026, 12:31Chandrashekhar Athare: EHA 2026 Concludes with Lasting Impact and New Collaborations
-
Jun 15, 2026, 10:49Marek Mráz: A Landmark EHA 2026 for Our Lab
-
Jun 15, 2026, 10:32Magnus Ek: Operational Excellence in Delivering Seamless Access for 17,000 Delegates at EHA 2026 Congress